G/TBT/N/BRA/1421  
12 August 2022  
(22-6129) Page: 1/2 
Committee on Technical Barriers to Trade  Original:  English  
 
  
NOTIFICATION  
The following notification is being circulated in accordance with Article 10.6  
 
1. Notifying Member:  BRAZIL  
If applicable, name of local government involved (Article 3.2 and 7.2):   
2. Agency responsible:  Brazilian Health Regulatory Agency (ANVISA)  
Name and address (including telephone and fax numbers , email and website 
addresses, if available) of agency or authority designated to handle comments 
regarding the notification shall be indicated if different from above:   
National Institute of Metrology, Quality and Technology (INMETRO)  
Telephone: +(55) 21 2145.3817  
Telefax: +(55) 21 2563.5637  
Email: barreirastecnicas@inmetro.gov.br  
Website: www.inmetro.gov.br/barreir astecnicas  
3. Notified under Article 2.9.2 [X], 2.10.1 [  ], 5.6.2 [  ], 5.7.1 [  ], 3.2 [  ], 7.2 [  ], 
other :  
4. Products covered (HS or CCCN where applicable, otherwise national tariff 
heading. ICS numbers may be provided in addition, where applicable):  
Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or 
more constituents which have been mixed together for therapeutic or prophylactic uses, 
not put up in measured doses or in forms or packings for retail sale. (H S code(s): 3003); 
Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or 
unmixed products for therapeutic or prophylactic uses, put up in measured doses 
(including those in the form of transdermal administration systems) or i n forms or 
packings for retail sale. (HS code(s): 3004)  
5. Title, number of pages and language(s) of the notified document:  Resolution - 
RDC number 730, 01 July 2022; (10 page(s), in Portuguese)  
6. Description of content:  This Resolution contains provisi ons on human health risk 
assessment of veterinary medicinal products, maximum residue limits (MRLs) of 
veterinary medicinal products in foods of animal origin and methods of analysis for 
conformity assessment purposes.  
Studies should be conducted and repo rted in accordance with updated protocols described 
in the Organization for Cooperation and Economic Development (OECD) or guidelines 
published in the  
International Conference on Harmonization of Veterinary Medicines (VICH) and follow the 
principles of Goo d Laboratory Practice (GLP).  
This resolution will also be notified to the SPS committee  
7. Objective and rationale, including the nature of urgent problems where 
applicable:  Protection of human health or safety  G/TBT/N/BRA/1421  
 
- 2 - 
 
  8. Relevant documents:  - 
9. Proposed date of adoption:  1 September 2022  
Proposed date of entry into force:  1 September 2022  
10. Final date for comments:  Not Applicable  
11. Texts available from:  National enquiry point [ ] or address, telephone and fax 
numbers and email and website addresses, if available , of other body:   
Brazilian Health Regulatory Agency (Anvisa)  
SIA, Trecho 5, Área Especial 57  
Brasília – DF / Brazil  
CEP: 71.205 -050 
Phone.: +(55) 61 3462.5402  
Website: www. anvisa.gov.br  
The final text is available only in Portuguese and can be downloaded at:  
http://antigo.anvisa.gov.br/documents/10181/2718376/RDC_730_2022_.pdf/0dfa65ac -
4176-414b-a130-564dac564e44